Omnaris Approval History
- FDA approved: Yes (First approved October 20th, 2006)
- Brand name: Omnaris
- Generic name: ciclesonide
- Dosage form: Nasal Spray
- Company: Altana Pharma
- Treatment for: Allergic Rhinitis
Omnaris (ciclesonide) is an intranasal corticosteroid indicated for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Development History and FDA Approval Process for Omnaris
|Oct 20, 2006||Omnaris Altana Pharma - Treatment for Allergic Rhinitis|
|Mar 7, 2006||Altana Submitted New Drug Applications For Ciclesonide Nasal Spray in the U.S. and Canada; Major Milestone in Broadening the Ciclesonide Product Platform|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.